Interpace Biosciences Inc (NASDAQ:IDXG)

3.51
BATS BZX Real-Time Price
As of 10:39am ET
 +0.02 / +0.57%
Today’s Change
2.57
Today|||52-Week Range
11.00
-29.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues9.4M13.1M15.9M21.9M
 
 
 
 
 
Cost of Goods Sold5.7M6.1M6.9M10.0M
 
 
 
 
 
Depreciation And Amortization5.0M4.3M3.7M3.5M
 
 
 
 
 
 
Operating ExpensesGross Income-1.3M2.7M5.3M8.4M
 
 
 
 
 
General Expenses27.7M17.6M18.7M19.0M
 
 
 
 
 
Research And Development2.3M1.6M1.5M2.1M
 
 
 
 
 
Total Operating Expenses38.4M28.0M29.3M32.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-29.0M-14.9M-13.4M-10.6M
 
 
 
 
 
Extraordinary Credit8.0M11.9M7.1M0.00
 
 
 
 
Extraordinary Charge-19.4M-3.4M-4.3M-1.5M
 
 
 
 
 
Interest Expense On Debt3.7M2.1M433.0K331.0K
 
 
 
 
 
Other Expenses-93.0K14.0K-2.1M263.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-44.2M-8.6M-13.1M-12.2M
 
 
 
 
 
Income Taxes-13.1M-162.0K-395.0K-18.0K
 
 
 
 
 
Discontinued Operations-1.9M-1.2M521.0K16.0K
 
 
 
 
 
Extraordinary Items21.6M1.3M0.000.00
 
 
 
Net Income-33.0M-9.7M-12.2M-12.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M1.8M15.8M28.2M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M1.8M15.8M28.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.30-$4.59-$0.78-$0.43
 
 
 
 
 
EPS Diluted-$21.32-$5.32-$0.77-$0.43